Upcoming Neuromodulation Event
Conference
April 14, 2026 | New York Academy of Medicine, New York, NY
An Investment and Management Conference for Entrepreneurs and Executives
This ninth annual meeting represents the premier management and investment conference for the new and emerging bioelectronic medicine industry. Attendees will have an exclusive opportunity to interact with some of the key leaders driving this field forward. The schedule of presentations and panel discussions features a host of experts with a wealth of information on the neuroscience industry and the investment community.
Sessions will cover a range of technologies and indications for bioelectronic medicine, including applications in cardiovascular medicine, inflammation, gastrointestinal disorders, and many other clinical specialties. Attendees will hear from some of the leading researchers and entrepreneurs developing clinically and commercially promising products such as implanted vagus nerve stimulation systems to treat hypertension, and surface stimulation devices to treat a range of disorders.
| 8:15-8:30 | Welcome and Introductions |
| 8:30-9:00 |
Overview of the Bioelectronic Medicine Industry James Cavuoto, Editor, Neurotech Reports BioElectRx Business Report Editor James Cavuoto presents an overview of the bioelectronic medicine industry, including recent events, key players, technological roots, and market projections. |
| 9:00-9:30 |
Keynote Address Michel Maharbiz, Ph.D., CEO, iota Biosciences A bioelectronic medicine industry executive and longtime industry observer offers their views on what lies ahead. |
| 9:30-10:15 |
Bioelectronic Medicine ROI Jeremy Koff, Senior Consulting Editor, Neurotech Reports, Moderator Allan Gobbs, Co-Founder and Managing Partner, ATEM Capital Adam Rosenwach, Founding Managing Partner, Star51 Capital Jeff Chu, Managing Partner, Features Capital Several recent high-profile exits and investment deals have raised the stakes for entrepreneurs and investors alike. In this session, venture capital professionals active in the life sciences industry will offer their views on the investment climate for bioelectronic medicine. |
| 10:15-10:45 | Refreshment Break |
| 10:45-11:30 |
Entrepreneur Panel I James Cavuoto, Editor, Neurotech Reports, Moderator Ben Woodington, Ph.D., CEO, Coherence Neuro Miguel Vilaplana, M.D., CEO, Graphenicalab SL Stefan Kampusch, Ph.D., CEO, Aurimod GmbH Presentations from executives of emerging bioelectronic medicine firms. |
| 11:30-12:15 |
Novel Diagnostics Drive New Therapies James Cavuoto, Editor, Neurotech Reports, Moderator Nandan Lad, M.D., Ph.D., Professor of Neurosurgery, Duke University Marom Bikson, Ph.D., Professor of Biomedical Engineering, CCNY Kiran Patel, M.D., Founder and CEO, NYC Neuromodulation Center of Excellence Advances in bioelectronic medicine have come not only from identifying new neuromodulation targets, but also from integrating novel biological signals into the therapeutic regimen. In this session, experienced investigators and entrepreneurs will offer their thoughts on how new thinking in bioelectronic medicine can yield new opportunities for life science firms. |
| 12:15-1:15 | Luncheon |
| 1:15-1:30 | Luncheon Speaker |
| 1:30-2:15 |
Improving Selectivity of Bioelectronic Therapies Victor Pikov, Ph.D., Contributing Editor, BioElectRx Business Report, Moderator Jay Jiang, Ph.D., CTO, Spiro Medical Esther Novosel, Ph.D., CEO, neuroloop GmbH The market for bioelectronic medicine will be driven by improvements in selective activation of both sympathetic and parasympathetic fibers. In this session, we'll look at some new products that have emerged as a result of advances in selective activation. |
| 2:15-3:00 |
Entrepreneur Panel II Jeremy Koff, Senior Consulting Editor, Neurotech Reports, Moderator Bryan McLaughlin, Ph.D., CEO, ExNeuro Amir Soltanianzadeh, CEO, StimCardio Medical Mehmet Gunal, Ph.D., CEO, Brill Neurotech Presentations from executives of emerging bioelectronic medicine firms. |
| 3:00-3:30 | Refreshment Break |
| 3:30-4:15 |
Emerging Market Segments JoJo Platt, Senior Contributing Editor, Neurotech Reports, Moderator Jeffrey Cohen, Director of Research, Ladenburg Thalmann John Propst, Ph.D., Managing Partner, Ground Effect Ventures Adam Caplan, Founder and General Partner, Jumpsapce Ventures In this session, we'll look at some of the new opportunities awaiting investors in the space. |
| 4:15-5:00 |
A Fireside Chat James Cavuoto, Editor, Neurotech Reports, Moderator Jennifer French, Executive Director, Neurotech Network Neurotech Reports editors chat with a key figure from the bioelectronic medicine industry. |
| 5:00-6:30 | Cocktail Reception |
Reserve your spot for the 2026 Bioelectronic Medicine Forum.
New York Academy of Medicine
New York, NY